Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30152% above fair value
$319.09−3.85 (-1.19%)
Close on Nov 13, 2026Market cap $46.00BP/E –Yield –
Natera profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Natera's profit margin for the twelve months ending Sep 30, 2026 was -5.7%. For fiscal 2025 it was -9.0%, against -11.2% the year before. The highest annual figure on record is -3.2% in fiscal 2014.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9.0% | +2.2 |
| FY2024 | Dec 31, 2024 | -11.2% | +28.9 |
| FY2023 | Dec 31, 2023 | -40.2% | +26.6 |
| FY2022 | Dec 31, 2022 | -66.8% | +8.6 |
| FY2021 | Dec 31, 2021 | -75.4% | −16.7 |
| FY2020 | Dec 31, 2020 | -58.8% | −17.5 |
| FY2019 | Dec 31, 2019 | -41.3% | +8.5 |
| FY2018 | Dec 31, 2018 | -49.7% | +15.9 |
| FY2017 | Dec 31, 2017 | -65.7% | −18.4 |
| FY2016 | Dec 31, 2016 | -47.2% | −10.3 |
| FY2015 | Dec 31, 2015 | -36.9% | −33.7 |
| FY2014 | Dec 31, 2014 | -3.2% | +64.0 |
| FY2013 | Dec 31, 2013 | -67.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -7.5% | +7.2 |
| Q2 FY2026 | Jun 30, 2026 | -8.9% | +9.6 |
| Q1 FY2026 | Mar 31, 2026 | -12.2% | +1.1 |
| Q4 FY2025 | Dec 31, 2025 | 7.1% | +18.4 |
| Q3 FY2025 | Sep 30, 2025 | -14.8% | −7.6 |
| Q2 FY2025 | Jun 30, 2025 | -18.5% | −9.4 |
| Q1 FY2025 | Mar 31, 2025 | -13.3% | +5.0 |
| Q4 FY2024 | Dec 31, 2024 | -11.3% | +13.8 |
| Q3 FY2024 | Sep 30, 2024 | -7.2% | +33.5 |
| Q2 FY2024 | Jun 30, 2024 | -9.1% | +33.3 |
| Q1 FY2024 | Mar 31, 2024 | -18.4% | +38.3 |
| Q4 FY2023 | Dec 31, 2023 | -25.1% | +40.5 |
| Q3 FY2023 | Sep 30, 2023 | -40.6% | +17.0 |
| Q2 FY2023 | Jun 30, 2023 | -42.4% | +30.8 |
| Q1 FY2023 | Mar 31, 2023 | -56.6% | +14.7 |
| Q4 FY2022 | Dec 31, 2022 | -65.6% | +15.6 |
| Q3 FY2022 | Sep 30, 2022 | -57.7% | +38.0 |
| Q2 FY2022 | Jun 30, 2022 | -73.2% | +8.5 |
| Q1 FY2022 | Mar 31, 2022 | -71.4% | −29.5 |
| Q4 FY2021 | Dec 31, 2021 | -81.2% | −13.2 |
| Q3 FY2021 | Sep 30, 2021 | -95.7% | −36.2 |
| Q2 FY2021 | Jun 30, 2021 | -81.7% | −12.7 |
| Q1 FY2021 | Mar 31, 2021 | -41.9% | −4.3 |
| Q4 FY2020 | Dec 31, 2020 | -68.0% | −25.7 |
| Q3 FY2020 | Sep 30, 2020 | -59.4% | −29.7 |
| Q2 FY2020 | Jun 30, 2020 | -69.0% | −25.4 |
| Q1 FY2020 | Mar 31, 2020 | -37.6% | +13.4 |
| Q4 FY2019 | Dec 31, 2019 | -42.3% | +5.3 |
| Q3 FY2019 | Sep 30, 2019 | -29.7% | +15.7 |
| Q2 FY2019 | Jun 30, 2019 | -43.6% | +10.0 |
| Q1 FY2019 | Mar 31, 2019 | -51.0% | +1.7 |
| Q4 FY2018 | Dec 31, 2018 | -47.5% | +43.2 |
| Q3 FY2018 | Sep 30, 2018 | -45.4% | +4.5 |
| Q2 FY2018 | Jun 30, 2018 | -53.6% | +2.0 |
| Q1 FY2018 | Mar 31, 2018 | -52.7% | +15.1 |
| Q4 FY2017 | Dec 31, 2017 | -90.7% | −13.8 |
| Q3 FY2017 | Sep 30, 2017 | -49.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -55.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -67.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -76.9% | – |
See a number that looks wrong?